Audrey Kunin, Chief Product Officer at NovaBay Pharmaceuticals, Inc. (NBY), sold 1 shares at $1.81 ($2) on 2022-12-06, disclosed to the SEC on 2022-12-07.
Open-market sale of $2 NBY by Chief Product Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBY | BUY | 2021-12-07 | $47K | — | Filing → |
| NBY | BUY | 2021-12-06 | $252K | — | Filing → |
| NBY | BUY | 2021-12-03 | $7K | — | Filing → |